Erasca has backed up bullish claims about its pan-RAS drug having a best-in-class profile, publishing phase 1 data that an analyst said reveal a “home run profile.” But with a patient dying and ...

With Flash GA, the company is attempting to transition from being a provider of raw compute to becoming the essential orchestration layer for the AI-first cloud.